TrialFinder  /  Landscape Report CEREBELLAR ATAXIA  ·  2026-10-26 Revasser  /  revasserkernel.com
Landscape Report TrialFinder
SOURCE  ClinicalTrials.gov API v2
GENERATED  2026-10-26
VERSION  v1
SAMPLE  100 of 554 studies

cerebellar ataxia

The cerebellar ataxia clinical trial landscape includes 554 actively recruiting trials. Semantic expansion identified 470 additional trials beyond exact-match search, representing a 559.5% discovery lift across related conditions and therapeutic approaches.

Recruiting
554
active trials
Expansion Lift
+559.5%
470 additional trials
Top Sponsor
Massachusetts Eye and Ear Infirmary
2 trials
Dominant Phase
NA
62 of 102 sampled
Pipeline Overview
Phase Distribution
NA
62
Early I
3
Phase 1
2
Phase 2
6
Phase 3
2
Phase 4
3
Other
24
Therapeutic Modalities
DEVICE
60
OTHER
49
DRUG
27
DIAGNOSTIC_TEST
18
PROCEDURE
12
BEHAVIORAL
9
COMBINATION_PRODUCT
1
Recruiting vs. Completed (2yr)
Recruiting
554
Completed
289
Competitive Landscape
Sponsor Classification
76%
10%
5%
5%
5%
OTHER (16)
NIH (2)
OTHER_GOV (1)
NETWORK (1)
INDUSTRY (1)
Top Sponsors
SponsorTrialsClass
Massachusetts Eye and Ear Infirmary2OTHER
University of Texas Southwestern Medical Center2OTHER
National Taiwan University Hospital2OTHER
National Institute of Neurological Disorders and Stroke (NINDS)2NIH
University Health Network, Toronto2OTHER
The Cleveland Clinic2OTHER
Monica Daibert Nido1OTHER
Azienda Usl di Bologna1OTHER_GOV
University of Patras1OTHER
Casa di Cura San Raffaele Cassino1NETWORK
Marquette University1OTHER
Swiss Federal Institute of Technology1OTHER
Vima Therapeutics1INDUSTRY
Universitätsklinikum Hamburg-Eppendorf1OTHER
Universidade Federal de Pernambuco1OTHER
Geographic Distribution
Top U.S. States by Trial Density
StateTrialsTop City
Florida16Miami
Texas13Dallas
Massachusetts10Boston
California9Sacramento
New York8New York
Ohio8Cleveland
North Carolina6Winston-Salem
Maryland5Bethesda
Arizona4Scottsdale
Washington4Spokane
Pennsylvania4Pittsburgh
Indiana3Indianapolis
Georgia3Atlanta
Kansas3Overland Park
Tennessee3Memphis
Colorado3Littleton
Illinois3Chicago
Louisiana3Metairie
Wisconsin2Milwaukee
Connecticut2Stamford
Expansion Intelligence
+559.5%
Discovery lift — trials found by semantic expansion that exact-match search misses entirely. This is the gap competitors don't see.
1
Exact
1
Parent
1
Region
4
Related
4
Comorbid
3
Therapeutic
Top Expansion Terms
  • ataxia Parent
  • cerebellar Region
  • spinocerebellar ataxia Related
  • Friedreich ataxia Related
  • episodic ataxia Related
  • ataxia telangiectasia Related
  • dysarthria Comorbid
  • nystagmus Comorbid
  • gait disorder Comorbid
  • tremor Comorbid

These terms are curated from clinical literature — not generated by a language model. Each captures trials that use variant nomenclature for the same underlying condition or therapeutic area.

Key Findings
What This Landscape Means for cerebellar ataxia
high
Standard searches miss 560% of relevant trials for cerebellar ataxia — semantic expansion across related conditions and therapeutic approaches is essential for complete landscape visibility.
470 additional trials found via expansion vs 84 exact matches
high
Phase 2 volume (6) significantly exceeds Phase 3 (2), indicating a pipeline bottleneck — most candidates are 2-4 years from potential approval.
Phase 2/Phase 3 ratio: 3.0x
Next Steps
Take Action on This Intelligence
//
Stay Current
Get alerted when new trials open for cerebellar ataxia and related conditions. Free tier monitors 1 condition weekly.
Set Up Alerts
[+]
Research Portal
Deploy this intelligence as your organization's permanent research hub — auto-updating, branded, zero hosting cost.
From $497
{<}
API Access
Integrate trial intelligence into your own tools. Full expansion engine, landscape analytics, real-time data.
View Plans
Top Recruiting Trials
20 actively recruiting studies
Biofeedback in Idiopathic Infantile Nystagmus Syndrome
Monica Daibert Nido n=34 CNIB Toronto, Ontario
Intervention DEVICE: Biofeedback Training — Microperimeter biofeedback training as described provides to the patient a variable frequency sound and a luminous stimu...
Eligibility Ages 5 Years – 17 Years
Contact Monica Daibert-Nido, MD · 4164819995 · monica.nido@uhn.com
VR and Orthoses for Rehabilitation in Multiple Sclerosis
Azienda Usl di Bologna n=12 IRCCS Istituto delle Scienze Neurologiche di Bologna - AUSL of Bologna Bologna, Bologna
Intervention OTHER: VR and walking brace-based gait rehabilitation — The study implements the use of VR and wearable sensors to enhance gait analysis in clinical practice. Participants will...
Eligibility Ages 18 Years – 65 Years
Contact Kevin Marcaccini · +390514966403 · kevin.marcaccini@ausl.bologna.it
"Balance, Gait, and Motion Analysis in Multiple Sclerosis"
University of Patras n=40 Division of Physical Medicine and Rehabilitation/Department of Surgery, University of Ioannina Medical School Ioannina
Eligibility Ages 18 Years
Contact Eirini Papakosta, PT, MSc cand. · +30 6972355224 · up1075912@ac.upatras.gr
Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
Casa di Cura San Raffaele Cassino n=600 San Raffaele Cassino Cassino, Frosinone
Intervention OTHER: Observation — In MARKERS-NDD up to 600 participants will be enrolled and followed longitudinally once identified, over the course of 1...
Eligibility Ages 10 Years
Contact Maria Francesca De Pandis, MD, PhD, Neurologist · 0776394740 · maria.depandis@sanraffaele.it
High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
Marquette University n=150 Rehabilitation Hospital of Indiana Indianapolis, Indiana
Intervention PROCEDURE: High-Intensity Treadmill Training — Participants will walk on a treadmill at a speed that produces 70-80% of age-adjusted heart rate reserve or a rating of ...
Eligibility Ages 18 Years – 75 Years
Contact Brian D Schmit, PhD · 4142886125 · brian.schmit@marquette.edu
Investigating Neural Biomarkers for Gait in Parkinson's Patients
Swiss Federal Institute of Technology n=60 Cereneo Vitznau, Canton of Lucerne
Intervention DIAGNOSTIC_TEST: Neural Activity Recording — Neural Activity is measured using EEG in all groups. Additionally, in Parkinson's patients, local-field-potentials from ...
Eligibility Ages 18 Years
Contact Lena Salzmann, MSc · +41788248679 · lena.salzmann@hest.ethz.ch
NCT07804615 PHASE2
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Vima Therapeutics n=80 Vima Site #039 Scottsdale, Arizona
Intervention DRUG: VIM0423 — VIM0423 is a combination drug product containing two active ingredients (VMA-1001 and VMA-1002)
Eligibility Ages 18 Years – 65 Years
Contact Study Director · 617-430-7027 · Clinicaltrials@vimatx.com
Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor
Universitätsklinikum Hamburg-Eppendorf n=10 Universitätsklinikum Hamburg-Eppendorf Hamburg, Free and Hanseatic City of Hamburg
Intervention DEVICE: Active-tACS — 30 seconds of closed-loop tACS at 2-4 mA, with 6 alternating phase alignments and 1-3 repetitions. Phase alignment is ad...
Eligibility Ages 18 Years
Contact Simone Zittel, Dr. med. · +49 40 7410 53770 · s.zittel-dirks@uke.de
Efficacy of Trans-spinal Magnetic Stimulation on Functional Mobility in Chronic Stroke Patients
Universidade Federal de Pernambuco n=30 Federal University of Paraiba João Pessoa, Paraíba
Intervention DEVICE: Trans-spinal magnetic stimulation — Trans-spinal magnetic stimulation activates afferent spinal roots and increases cortical excitability.
Eligibility Ages 18 Years – 75 Years
Contact Daniel G Melo, Physical Therapy · 55 + 81995173332 · gmelodaniel@gmail.com
Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia
Mclean Hospital n=68 McLean Hospital Belmont, Massachusetts
Intervention DEVICE: Repetitive Transcranial Magnetic Stimulation (rTMS) — rTMS is a technique of TMS that allows for selective external manipulation of neural activity in a non-invasive manner. ...
Eligibility Ages 18 Years – 55 Years
Contact Mark Halko, PhD · mhalko@mclean.harvard.edu
NCT05216770 EARLY_PHASE1
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
Massachusetts Eye and Ear Infirmary n=165 Massachusetts Eye and Ear and University of California San Francisco Boston, Massachusetts
Intervention OTHER: Brain imaging — Brain images will be conducted with function MRI, magnetoencephalography (MEG), and electroencephalography (EEG) to iden...
Eligibility Ages 18 Years – 80 Years
Contact Kristina Simonyan, MD, PhD · 617-573-6016 · simonyan_lab@meei.harvard.edu
Neurosurgical Outcome Network
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta n=4500 1. ASST Papa Giovanni XXIII Bergamo, BG
Eligibility Ages 18 Years
Contact Paolo Ferroli, MD · +39 02 2394 2411 · paolo.ferroli@istituto-besta.it
Foot Strengthening to Improve Balance and Gait in Older Adults
Indiana University n=160 School of Public Health-Bloomington Bloomington, Indiana
Intervention DEVICE: Minimalist footwear — Habitual use of low-cushion, low-structure footwear designed to increase intrinsic foot muscle engagement during daily a...
Eligibility Ages 45 Years
Contact Marni Wasserman, MS · 812-856-2447 · marnwass@iu.edu
Cerebellar tDCS in Children With Autism Spectrum Disorder
University of Texas Southwestern Medical Center n=60 Children's Medical Center Dallas, Texas
Intervention DEVICE: tDCS — A current of 1 mA will be administered for 20 minutes of with either anodal or cathodal tDCS administration to the right...
Eligibility Ages 4 Years – 17 Years
Contact Peter Tsai, MD, PhD · 214-648-3577 · peter.tsai@utsouthwestern.edu
Posterior Fossa Intracranial Pressure (ICP) Measurement: Clinical Study
University of Valencia n=12 Hospital General Universitario de Valencia Valencia, Valencia
Intervention PROCEDURE: Posterior fossa intracranial pressure measurement — Measurement of posterior fossa pressure in an invasive way
Eligibility Ages 18 Years – 80 Years
Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease
National Taiwan University Hospital n=5 National Taiwan University Hospital Hsin-Chu Branch Hsinchu, Hsinchu City
Intervention DEVICE: SCS electrode stimulation 1 — 300Hz/300us
Eligibility Ages 40 Years – 85 Years
Contact Kai-Hsiang Chen, M.D. · +886-3-5326151 · stanleychen1230@gmail.com
Impact of Mirror Therapy Combined With Conventional Training on Gait and Lower Limb Motor Function Among Post-Stroke Patients
Ibadat International University, Islamabad n=52 Department of Physical Therapy at suleman medical complex hospital, Quetta. Quetta, Balochistan
Intervention OTHER: Mirror Therapy Based Functional Training — (Basic) - Sitting position: * Ankle dorsiflexion/plantarflexion (simulating pressing a gas pedal) * Knee extension/flex...
Eligibility Ages 40 Years – 70 Years
Contact Muhammad Ammar Muhammad Ammar, DPT, MS-PT NPT · +923138092081 · ammarkhanazxc36@gmail.com
Biomarker Research in Inherited Movement Disorders
Assistance Publique - Hôpitaux de Paris n=4000 Hôpital Pitié Salpetrière Paris
Intervention OTHER: Clinical follow-up — Clinical Follow-up: demographic data and history, * Retrospective interview (collection of data useful for genetic stu...
Eligibility Ages 7 Years
Contact Alexandra DURR, PUPH · 142161347 · alexandra.durr@aphp.fr
NCT04460872 PHASE2
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
North Florida Foundation for Research and Education n=21 North Florida/South Georgia Veterans Health System Gainesville, Florida
Intervention DRUG: Testosterone Enanthate — Subjects receive testosterone (100 mg/week) by intramuscular injection
Eligibility Ages 18 Years, MALE only
Contact Joshua F Yarrow, PhD · (352) 548-6477 · joshua.yarrow@va.gov
Evaluating the Impact of Virtual Reality on Mood in Patients Undergoing Magnetic Resonance-Guided Focused Ultrasound for Medication-Refractory Essential Tremor
Sunnybrook Health Sciences Centre n=60 Sunnybrook Health Sciences North York, Ontario
Intervention DEVICE: VR headset: video number 1 — A 6-minute virtual reality (VR) video that contains sights and sounds that might affect mood. The video is viewed on a M...
Eligibility Ages 18 Years
Contact Leila Harwood · 4167796698 · leila.harwood@sunnybrook.ca